Lunit Inc.
328130
Clasificación en acciones
#11589
Lunit Inc., established in 2013 and headquartered in Seoul, South Korea,... Lunit Inc., established in 2013 and headquartered in Seoul, South Korea, develops and supplies advanced artificial intelligence software solutions aimed at improving cancer screening, diagnosis, and treatment. The company's portfolio includes AI-powered tools for analyzing medical images like chest X-rays and mammograms, as well as intelligent biomarkers for immune phenotyping and precise PD-L1 quantification, which are vital for optimizing immunotherapy.
Precio por acción
$8.70
Capitalización bursátil
$647.05M
Cambio (1 día)
-2.71%
Cambio (1 año)
1,042.24%
País
KR
Comercio Lunit Inc. (328130)
Categoría
Healthcare
Ratio P/S de Lunit Inc. (328130)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Lunit Inc., el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Lunit Inc. desde 2026 hasta 2026
Ratio P/S al final de cada año
| Año | Ratio P/S | Cambiar |
|---|---|---|
| Not enough data for the provided dates. | ||
Ratio P/S de empresas similares o competidoras
| Empresa | Ratio P/S | Diferencia del ratio P/S | País |
|---|---|---|---|
| 1.53 | - |
US
|
|
| 65.30 | - |
AU
|
|
| 0.87 | - |
US
|
|
| 8.37 | - |
US
|
|
| 15.04 | - |
US
|
